Law firm Mills & Reeve has appointed Dan Braithwaite as a principal associate in its health and social care mergers and acquisitions practice.
Closed Loop Medicine: Konstantinos Vlassis
Cambridge-based Closed Loop Medicine, a techbio company developing combination prescription drug plus software therapy products that enable personalised dose optimisation, has appointed Konstantinos Vlassis as chief technology officer.
Vlassis will oversee the management of the company’s technology platforms with responsibility for engineering, information security and technology infrastructure and facilitating cross-functional collaboration.
Vlassis has 20 years’ experience of designing and implementing technology strategies to support product delivery. He was previously chief technology officer at Medis Medical Imaging and, before that, interim chief technology officer at Winnow Systems.
Vlassis said: “I am thrilled to be joining Closed Loop Medicine and becoming an integral part of the development of our technology platform and overall software engineering, information security, and infrastructure to support bringing these life-changing products to the market. I am excited to work closely with the product, regulatory and operational teams to leverage the capabilities of our groundbreaking technologies that have the potential to revolutionise disease management and improve health outcomes for millions of patients.”
Dr Hakim Yadi, co-founder and chief executive of Closed Loop Medicine, commented: “It has been a pivotal year for the company’s growth, particularly to establish strategic collaborations and strengthen our senior leadership team. As chief technology officer, Konstantinos brings a wealth of experience in designing and implementing productive, transparent, accountable technology strategies within strict regulatory constraints and delivering innovative products. As we continue to develop our dose optimisation combination products enabling bespoke treatment decisions at an individual patient level, the expertise Konstantinos brings to the team is invaluable and I’m delighted to welcome him to the team.”
Latest Executive Moves
Cancer Research Horizons has appointed Jonathan Tobin and Genghis Lloyd-Harris as advisory investors-in-residence in its ventures team.Pharma